Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M819Revenue $M1.1Net Margin (%)-3,128.4Z-Score38.2
Enterprise Value $M743EPS $-1.2Operating Margin %-3,118.6F-Score4
P/E(ttm))0Cash Flow Per Share $-0.9Pre-tax Margin (%)-2,381.5Higher ROA y-yY
Price/Book11.310-y EBITDA Growth Rate %0Quick Ratio20.3Cash flow > EarningsY
Price/Sales7345-y EBITDA Growth Rate %0Current Ratio20.3Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-46.1Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-55.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M27.9ROI % (ttm)-59.8Gross Margin Increase y-yN

Gurus Latest Trades with NLNK

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NLNKJean-Marie Eveillard 2014-03-31 Add0.02%$21.38 - $50.4
($33.68)
$ 29.35-13%Add 28.35%1,161,805
NLNKJean-Marie Eveillard 2013-09-30 Add0.01%$15.78 - $20.08
($17.83)
$ 29.3565%Add 21.32%778,354
NLNKJean-Marie Eveillard 2013-06-30 Add0.02%$11.27 - $22.56
($15.73)
$ 29.3587%Add 95.04%641,554
NLNKJean-Marie Eveillard 2013-03-31 Buy 0.01%$11.4 - $12.7
($12.08)
$ 29.35143%New holding, 328939 sh.328,939
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NLNK is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
NLNK Jean-Marie Eveillard 2014-06-301,306,9704.680.08+12.49%
NLNK - CALLJean-Marie Eveillard 2014-06-307,1470.030.01
Premium Most recent portfolio changes are included for Premium Members only!


NLNK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Link Charles J. Jr.Chairman of the Board and CEO 2014-10-06Sell20,000$22.7229.18view
Ramsey William J.Quality Assurance Officer 2014-10-01Sell2,500$23.2526.24view
Link Charles J. Jr.Chairman of the Board and CEO 2014-09-05Sell20,000$25.6814.29view
Ramsey William J.Quality Assurance Officer 2014-09-02Sell2,500$26.411.17view
Link Charles J. Jr.Chairman of the Board and CEO 2014-08-05Sell18,000$21.8334.45view
Ramsey William J.Quality Assurance Officer 2014-08-01Sell2,500$20.4343.66view
Link Charles J. Jr.Chairman of the Board and CEO 2014-07-08Sell20,000$2612.88view
Ramsey William J.Quality Assurance Officer 2014-07-01Sell2,500$27.337.39view
Ramsey William J.Quality Assurance Officer 2014-06-06Sell66$2046.75view
Link Charles J. Jr.Chairman of the Board and CEO 2014-06-03Sell20,000$19.0653.99view

Press Releases about NLNK :

    Quarterly/Annual Reports about NLNK:

    News about NLNK:

    Articles On GuruFocus.com
    NewLink Genetics Corporation Offers a Risky Way to Generate Income Sep 11 2013 
    Weekly CEO Sells Highlight: Universal Insurance Holdings Inc, Avanir Pharmaceuticals Inc, Bel Fuse I Jun 30 2012 

    More From Our Partners
    Stomach-Churning Ride for Ebola Stocks Oct 17 2014 - FOXBUSINESS

    More From Other Websites
    [$$] Canada Ships Out Experimental Ebola Vaccine Oct 18 2014
    NewLink Genetics (NLNK) Shows Strength: Stock Up 23.7% Oct 14 2014
    Newlink shares jump on start of Ebola vaccine study Oct 13 2014
    Mali health workers get experimental GSK vaccine in Ebola trials Oct 10 2014
    Hazmat Suit Maker Lakeland Soars On Dallas Ebola Fear Oct 09 2014
    The Ebola drug playbook Oct 07 2014
    [video] The Ebola drug playbook Oct 07 2014
    [video] First Ebola case contracted outside West Africa: Report Oct 06 2014
    First Ebola case contracted outside West Africa: Report Oct 06 2014
    [video] Ebola patient gets Chimerix's drug Oct 06 2014
    Ebola patient gets Chimerix's drug Oct 06 2014
    [video] Dallas patient with Ebola in critical condition Oct 06 2014
    Dallas patient with Ebola in critical condition Oct 06 2014
    CFO Moves: Turner Broadcasting, NewLink Genetics, Ipsen Group Oct 02 2014
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NewLink Genetics... Oct 02 2014
    NEWLINK GENETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers Oct 01 2014
    NewLink Genetics Corporation Announces Appointment of New Executive Vice President and Chief... Oct 01 2014
    Ebola stocks: Who's leading? Oct 01 2014
    [video] Ebola stocks: Who's leading? Oct 01 2014
    Ebola-Related Pharma Stocks Soar On First U.S. Case Oct 01 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK